Cite
MLA Citation
Daniel A Orringer et al.. “First in Human Phase I Trial of Dual Vector (HSV1‐TK, Flt3L) Immunotherapy For The Treatment of Newly Diagnosed High‐Grade Glioma: Initial Results.” Neurosurgery, vol. 66, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100169172907.0x00004e